kabutan

RIKEN VITAMIN, First Half Ordinary Profit Decreases by 9%

Thu Nov 13, 2025 4:00 pm JST Earnings

4526 RIKEN VITAMIN CO.,LTD. 【J-GAAP】

Earnings Report

RIKEN VITAMIN CO.,LTD. <4526> [TSE Prime] announced its financial results after the market closed on November 13th (16:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) decreased 8.7% from the same period last year to 4.36 billion yen. Progress toward the full-year plan of 9.00 billion yen was 48.5%, almost the same as the five-year average of 49.0%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to nearly flat at 4.63 billion yen, up 0.02% from the same period last year.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit amounted to 1.83 billion yen, a 1.2% decrease compared to the same period last year. The operating profit margin worsened from 8.9% in the same period last year to 7.2%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 44,613 4,596 5,220 3,667 111.7 50.7 Nov 10, 2023 J-GAAP
Apr - Sep, 2024 47,149 4,626 4,786 3,255 107.2 50.8 Nov 13, 2024 J-GAAP
Apr - Sep, 2025 47,265 4,091 4,368 3,361 113.0 48.5 Nov 13, 2025 J-GAAP
YoY +0.2% -11.6% -8.7% +3.3% +5.4%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance 49,000 4,000 4,400 2,900 97.9 55 May 14, 2025 J-GAAP
Apr - Sep, 2025 Results 47,265 4,091 4,368 3,361 113.0 55 Nov 13, 2025 J-GAAP
Revision Rate -3.5% +2.3% -0.7% +15.9% +15.4%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 48,433 4,098 4,631 6,133 202.6 53.50 May 14, 2025 J-GAAP
Oct - Mar, 2025 Guidance 52,735 4,409 4,632 4,839 164.5 55 Nov 13, 2025 J-GAAP
YoY +8.9% +7.6% +0.0% -21.1% -18.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 91,484 9,371 10,296 8,755 268.4 81 May 10, 2024 J-GAAP
Mar, 2025 95,582 8,724 9,417 9,388 310.1 94 May 14, 2025 J-GAAP
Mar, 2026 Guidance 100,000 8,500 9,000 8,200 278.8 110 May 14, 2025 J-GAAP
YoY +4.6% -2.6% -4.4% -12.7% -10.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 23,523 2,104 1,859 885 29.2 8.9 Nov 13, 2024 J-GAAP
Oct - Dec, 2024 25,703 2,918 3,455 2,579 85.0 11.4 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 22,730 1,180 1,176 3,554 117.4 5.2 May 14, 2025 J-GAAP
Apr - Jun, 2025 23,257 2,365 2,531 1,825 61.2 10.2 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 24,008 1,726 1,837 1,536 51.7 7.2 Nov 13, 2025 J-GAAP
YoY +2.1% -18.0% -1.2% +73.6% +77.2%

Related Articles